Levonadifloxacin arginine is a broad-spectrum anti-staphylococcal agent active against both methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA); it reduces the phagocytosis of MRSA and MSSA strains by THP-1 monocytes.